Wilbert S. Aronow, M.D., has edited more than 20 books and is the author or co-author of 2,000+ papers, more than 200 chapters in 100+ books, nearly 1,000 commentaries, 50 Letters to the Editor, 1,200+ abstracts, and is a presenter or co-presenter of more than 1,600 talks at meetings. Dr. Aronow has been a member of almost 200 editorial boards of medical journals. He has been a member of 4 national guidelines committees including being a coauthor of the 2010 AMDA guidelines for heart failure, a co-chair and first author of the 2011 ACC/AHA expert consensus document on hypertension in the elderly, a coauthor of the 2015 AHA/ACC/ASH scientific statement on treatment of hypertension in patients with coronary artery disease, and a coauthor of the 2017 ACC/AHA guidelines for the management of patients with hypertension. He was a co-author of a 2015 position paper from the International Lipid Expert Forum. Dr. Aronow has been a committee member of numerous professional societies and a consultant to many government agencies. He has mentored more than 1,300 physicians and medical students and has 1,700+ papers listed on PubMed during his professional career.

Education

  • Fellowship: Cardiology
  • Residency: Internal Medicine 
  • M.D., Harvard Medical School

Areas of Expertise

  • Cardiovascular Disease
  • Preventive Cardiology

Honors and Awards

  • 90 Honors including NYMC Chancellor's Research Award
  • 2 NYMC 2021 Excellence in Teaching Dean's Faculty Award
  • NYMC library 2024 Award for mentoring residents

Publications

  • Gopu SS, Khader AHSA, Agrawal SP, et. al. "Osimertinib-Associated Cardiotoxicity in EGFR-Mutant Non-Small Cell Lung Cancer: Mechanisms, Phenotypes, and Surveillance." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001437
  • Wu C, Gastelum S, Al-Fakhoury J, et. al. "Cardiovascular Effects of Kratom (Mitragyna speciosa)." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001438
  • Arundel C, Raman VK, Zhang S, et. al. "Inpatient Initiation of Target-Dose ACE Inhibitors and Lower Risk of Death or Kidney Failure in Veterans With HFrEF: Results From the National DCVA-HF Registry." Journal of cardiac failure, (), (2026) . pii: S1071-9164(26)00498-7. doi: 10.1016/j.cardfail.2026.08.007
  • Nguyen ND, Fishkin T, Makaryus AN, et. al. "Pediatric Hyperlipidemia Guidelines: A Comprehensive Review of Screening, Diagnosis, and Management." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001433
  • Itani H, Moumneh MB, Zayed A, et. al. "Updates on Imaging Modalities for the Diagnosis of Aortic Stenosis." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001435
  • Elkasaby MH, Alanazi AA, Frishman WH, et. al. "Complete Revascularization Versus Culprit-Only Percutaneous Coronary Intervention in Non-ST-Elevation Myocardial Infarction With Multivessel Disease: A Nationwide Propensity Score-Matched Analysis." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001431
  • Ali A, Thirumavalavan D, Catanzaro JN, et. al. "Pompe Disease: From a Cardiovascular Lens." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001432
View All Publications

Memberships and Affiliations

  • FACC
  • FAHA
  • FACP
  • FCCP
  • FASPC
  • AGSF
  • FGSA

Teaching Responsibilities

  • Mentor cardiology fellows
  • Mentor medical residents
  • Mentor medical students